Thesis pillars
- Solid Growth And Cash Flow→Stable
- Perfect Earnings Beat Streak↓Deteriorating
- Price Above Analyst Target↓Deteriorating
- +2 more pillars — see the Why tab for full reasoning
Pillars as of Oct 24, 2026, based on the 10-K filed Mar 9, 2026
908 Devices Inc. (MASS) Stock Analysis
Breakout setup · Catalyst-Driven edge
Healthcare · Medical Devices
Sell if holding. At $12.87, A.R:R is negative (-0.8) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Product: handheld products; Concentration risk — Supplier: single source suppliers and subassembly manufacturers.
908 Devices makes handheld chemical-analysis devices — including the MX908, ThreatID, ProtectIR, XplorIR, and VipIR — that use miniaturized mass spectrometry and optical spectroscopy to detect fentanyl, explosives, and other hazards at the point of need for first responders,... Read more
Sell if holding. At $12.87, A.R:R is negative (-0.8) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Product: handheld products; Concentration risk — Supplier: single source suppliers and subassembly manufacturers. Chart setup: Golden cross, above all MAs, RSI 65, MACD bullish. Score 5.4/10, moderate confidence.
Passes 5/8 gates (positive momentum, no SEC red flags, news events none recent, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio and clean insider activity. Suitability: aggressive.
About 908 Devices Inc.
About 908 Devices Inc.
908 Devices has sold more than 3,700 handheld chemical-analysis devices — led by the MX908 mass-spectrometry unit and the FTIR-based ThreatID, ProtectIR, XplorIR, and VipIR product line — to over 700 customers, including numerous domestic and foreign government agencies, since launching its first device in 2014. Substantially all of the company's 2025 revenue came from these handheld products, sold into every U.S. state and across five continents to first responders, military, customs, and homeland security customers.
908 Devices earns revenue primarily from device sales plus a growing recurring stream from consumables, extended warranty service plans, and its Reachback technical-support program, sold through a mix of direct sales and domestic and international channel partners; in 2025, channel partners accounted for a significant portion of total revenue. The company depends on a limited number of large orders from U.S. government agencies for a substantial portion of its revenue in any given quarter, and its sales cycle can run from several months to over a year given government budget-approval and competitive-bidding processes. Manufacturing relies on single-source suppliers and subassembly manufacturers for certain components, a dependency the 10-K flags as a source of potential service interruption. The company's April 2024 acquisition of CAM2 Technologies (RedWave) added vibrational spectroscopy capabilities that complement its core Mass Spec platform, and its research and development team of 43 full-time employees is heavily weighted toward advanced science and engineering degrees.
Show full overview
908 Devices' revenue is concentrated on both the supply and demand sides at once: on demand, the 10-K cites dependence on a limited number of large orders from U.S. government agencies for a substantial portion of quarterly revenue, so a delayed federal budget approval alone can push revenue into a later period. On supply, the company relies on single-source suppliers and subassembly manufacturers for certain components, and states it cannot guarantee it could locate alternative sources on acceptable terms, or at all, if one were disrupted. Because substantially all revenue comes from a single handheld-device product line, either failure point flows straight through to the top line with limited offsetting revenue elsewhere.
See also: Healthcare · Medical Devices
From 908 Devices Inc.'s most recent 10-K filing, extracted August 23, 2026.
Recent developments
updated 2026-10-29Recent Developments — 908 Devices Inc.
Latest news
- NEWS Trading plan drives 27K-share insider sale at 908 Devices (MASS) - Stock Titan — Stock Titan negative
- NEWS Trading plan drives 27K-share insider sale at 908 Devices (MASS) - stocktitan.net — stocktitan.net negative
- NEWS Devices (MASS) Notches +4.64% Gain — Bulls Tighten Grip 2026-09-17 - Sector Leader Stocks - dars.gov.et — dars.gov.et positive
- NEWS Sea dragon populations decimated in ‘mind-blowing’ mass mortality event caused by South Australian algal bloom - The Gua — The Guardian negative
- NEWS 908 Devices Inc (NASDAQ: MASS) Share Price, MASS Stock News, MASS Share Price & Updates - Kalkine — Kalkine neutral
Generated 2026-10-29T11:48:40Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHProducthandheld products10-K Item 1A: 'In 2025, substantially all of our revenue was derived from sales of our handheld products.'
- MEDIUMCustomerU.S. government agencies10-K Item 1A: 'our dependence on a limited number of large orders from U.S. government agencies for a substantial portion of our revenue'
- MEDIUMCustomerchannel partners10-K Item 1A: 'our channel partners accounted for a significant portion of our total revenue'
- HIGHSuppliersingle source suppliers and subassembly manufacturers10-K Item 1A: 'service interruptions with any of our single source suppliers or subassembly manufacturers'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
2 floor-breakers
Priced at a premium — multiples above sector norms. Needs delivery on growth + margins to justify.static
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. At $12.87, A.R:R is negative (-0.8) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Product: handheld products; Concentration risk — Supplier: single source suppliers and subassembly manufacturers. Chart setup: Golden cross, above all MAs, RSI 65, MACD bullish. Prior stop was $11.97. Score 5.4/10, moderate confidence.
Analyst target $11.37 reached (−11.7% from $12.87); no take-profit level is published. Prior stop was $11.97. Stop-loss: $11.97.
Concentration risk — Product: handheld products; Concentration risk — Supplier: single source suppliers and subassembly manufacturers; Analyst target reached - limited upside remaining.
908 Devices Inc. trades at a P/E of N/A (forward -41.9). TrendMatrix value score: 3.5/10. Verdict: Sell.
12 analysts cover MASS with a consensus score of 4.3/5. Average price target: $13.
What does 908 Devices Inc. do?908 Devices makes handheld chemical-analysis devices — including the MX908, ThreatID, ProtectIR, XplorIR, and VipIR —...
908 Devices makes handheld chemical-analysis devices — including the MX908, ThreatID, ProtectIR, XplorIR, and VipIR — that use miniaturized mass spectrometry and optical spectroscopy to detect fentanyl, explosives, and other hazards at the point of need for first responders, military, and government agencies. Since 2014, the company has sold more than 3,700 handheld devices to over 700 customers, with substantially all 2025 revenue derived from handheld products and a substantial portion tied to large orders from U.S. government agencies.